SCHEMBL31660140

SCHEMBL31660140

CCOc1ccc(-c2cc(-c3ccc(C)c(C)c3)n[nH]2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.54
TP53 P04637 3/20 0.54
RAB9A P51151 3/20 0.54
NPC1 O15118 2/20 0.54
MAPK1 P28482 1/20 0.54
ALPL P05186 2/20 0.51
ALDH1A1 P00352 3/20 0.49
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP19A1 P11511 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
TDP1 Q9NUW8 2/20 0.47
CA9 Q16790 1/20 0.46
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
ALOX12 P18054 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26093604 1.00 MAPT (0.54) MAPTTP53RAB9ANPC1MAPK1
SCHEMBL26465139 0.94 MAPT (0.57) MAPTTP53RAB9ANPC1MAPK1
SCHEMBL14985536 0.79 RAB9A (0.68) MAPTTP53RAB9ANPC1MAPK1
SCHEMBL12243303 0.77 ALPL (0.68) MAPTTP53RAB9ANPC1MAPK1
SCHEMBL17279895 0.76 RAB9A (0.53) MAPTRAB9ANPC1MAPK1ALPL
SCHEMBL8891567 0.76 MAPT (0.60) MAPTTP53RAB9ANPC1MAPK1
SCHEMBL12243302 0.76 NPC1 (0.70) MAPTTP53RAB9ANPC1MAPK1
SCHEMBL17279915 0.75 CYP2D6 (0.62) MAPTRAB9ANPC1MAPK1ALPL
SCHEMBL9736398 0.75 DYRK1A (0.69) MAPTTP53RAB9ANPC1ALPL
SCHEMBL14387545 0.74 ALPL (0.57) MAPTTP53RAB9ANPC1ALPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250228242-A1 PROTEIN AGGREGATION INHIBITING COMPOUNDS FOR PLANT DISEASE CONTROL MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250228242-A1 PROTEIN AGGREGATION INHIBITING COMPOUNDS FOR PLANT DISEASE CONTROL APP, APBA1, PRNP MAPT 8/4885TP53 2542/4885RAB9A 1693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.